维普期刊资源整合服务平台（V6.5）

207篇 您的检索式：作者名="Fliser D"

选中清除导出查看参考文献查看引证文献引用追踪共11页首页上一页第1页下一页末页 /11 跳转

	题名	作者	年代	出处	被引量
1	Clinical relevance of FGF23 in chronic kidney disease显示文摘	Seller S Heine G H Fliser D	2009	Kidney Int Suppl2009，114，76：	1
2	Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans 显示文摘	Fliser D Franek E Fode P	1997	Nephrol Dial Transplant1997，12，5：	1
3	Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease显示文摘	Fliser D Pacini G Engelleiter R	1998	Kidney Int1998，53，5：	1
4	Insulin resistance and renal disease 显示文摘	Fliser D Kielstein JT Menne J	2006	Contrib Nephrol2006，151，：	1
5	Serum cystatin C concertration as a marker of renal dysfunction in the elderly显示文摘	Ritz E	2001	Am J Kidney Dis2001，37，1：	1
6	Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease显示文摘	Fliser D Pacini G Engelleiter R	1998	Kidney Int1998，53，：	1
7	A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury:Part 1:definitions,conservative management and contrast-induced nephropathy显示文摘	Fliser D Laville M Covic A		0，，：	1
8	Anti-inflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with micro-inflammation显示文摘	Fliser D Buchholz K Haller H	2004	Circulation2004，110，9：	1
9	Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the mild to moderate kidney disease (MMKD) study 显示文摘	Fliser D Kollerits B Neyer U	2007	J Am Soc Nephrol2007，18，：	1
10	FGF-23: the rise of a novel cardiovascular risk marker in CKD 显示文摘	HEINE GH SELLER S FLISER D	2012	Nephrol Dial Transplant2012，27，8：	1
11	Advances in urinary proteome analysis and biomarker discovery显示文摘	Fliser D Novak J Thongboonkerd V	2007	J Am Soc Nephrol2007，18，4：	1
12	A European Renal Best Practice(ERBP)position statement on the Kidney Disease Improving Global Outcomes(KDIGO)clinical practice guidelines on acute kidney injury:part 1:definitions,conservative management and contrast-induced nephropathy显示文摘	Ad-hoc working group of ERBP Fliser D Laville M	2012	Nephrol Dial Transplant2012，27，12：	1
13	A European Renal Best Practice(ERBP) posi- tion statement on the Kidney Disease Improving Global Out- comes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy显示文摘	Ad-hoc Working group of ERBP Fliser D Laville M Cov- ic A	2012	Nephrol Dial Transplant2012，27，12：	1
14	A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury :part 1 :definitions, conservative management and contrast-induced nephropathy显示文摘	Fliser D Laville M Covic A	2012	Nephrol Dial Transplant2012，27，12：	1
15	Serum cystatin C concentration as a marker of renal dysfunction in the elderly 显示文摘	Fliser D Ritz E	2001	Am J Kidney Dis2001，37，1：	1
16	Serum cystatin C concentratin as a marker of renal dysfunction in the elderly显示文摘	Ritz E	2001	Am J Kidney Dis2001，37，1：	1
17	Insulin resistance and renal disease显示文摘	Fliser D Kielstein JT Menne J	2006	Contrib Nephrol2006，151，：	1
18	Insulin resistance and hyperinsulinemia are already pre'sent in patients with incipient renal disease显示文摘	Fliser D Pacini G Engelleiter R	1998	Kidney Int1998，53，5：	1
19	Fibroblast growth factor 23 ( FGF23 ) predicts progression of chronic kidney disease : the Mild to Moderate Kidney Disease (MMKD) Study显示文摘	Fliser D Kollerits B Neyer U	2007	J Am Soc Nephrol2007，18，9：	1
20	Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure 显示文摘	Ortiz A Covic A Fliser D	2014	The Lancet2014，383，9931：	1

返回顶部每页显示：

共11页首页上一页第1页下一页末页 /11 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示